Richard Bernstein Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Richard Bernstein Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Hold	3,367	–	–	0.04%	120
2025 Q4	$1.53M	Sell	3,367 -325	-9%	-$140K	0.04%	90
2025 Q3	$1.45M	Sell	3,692 -4,059	-52%	-$1.7M	0.04%	137
2025 Q2	$3.45M	Sell	7,751 -855	-10%	-$394K	0.09%	118
2025 Q1	$4.17M	Sell	8,606 -444	-5%	-$207K	0.1%	92
2024 Q4	$3.64M	Hold	9,050	–	–	0.08%	129
2024 Q3	$4.21M	Hold	9,050	–	–	0.09%	100
2024 Q2	$4.24M	Buy	9,050 +2	+0%	+$868	0.09%	79
2024 Q1	$3.78M	Hold	9,048	–	–	0.08%	102
2023 Q4	$3.68M	Sell	9,048 -2,684	-23%	-$992K	0.08%	86
2023 Q3	$4.08M	Hold	11,732	–	–	0.09%	73
2023 Q2	$4.13M	Sell	11,732 -1,596	-12%	-$538K	0.09%	72
2023 Q1	$4.2M	Hold	13,328	–	–	0.09%	82
2022 Q4	$3.85M	Hold	13,328	–	–	0.09%	94
2022 Q3	$3.86M	Hold	13,328	–	–	0.1%	98
2022 Q2	$3.75M	Buy	+13,328	New	+$3.57M	0.08%	121
2020 Q2	–	Sell	-3,364	Closed	-$800K	–	276
2020 Q1	$800K	Sell	3,364 -11,286	-77%	-$2.59M	0.03%	171
2019 Q4	$3.21M	Hold	14,650	–	–	0.1%	148
2019 Q3	$2.48M	Sell	14,650 -5,958	-29%	-$1.05M	0.08%	171
2019 Q2	$3.78M	Hold	20,608	–	–	0.13%	127
2019 Q1	$3.79M	Hold	20,608	–	–	0.12%	139
2018 Q4	$3.42M	Hold	20,608	–	–	0.13%	158
2018 Q3	$3.97M	Buy	+20,608	New	+$3.67M	0.11%	193

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Richard Bernstein Advisors's VRTX Position: Q1 2026 in Review

Richard Bernstein Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 3,367 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #120.

Richard Bernstein Advisors first reported a position in VRTX in Q3 2018 and has held it in 23 quarters since. The position peaked at $4.24M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Richard Bernstein Advisors held 3,367 shares of Vertex Pharmaceuticals worth $1.5M as of Q1 2026.
Richard Bernstein Advisors left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
Vertex Pharmaceuticals made up 0.04% of Richard Bernstein Advisors's portfolio in Q1 2026, its #120 holding.
Richard Bernstein Advisors first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 23 quarters since.
Richard Bernstein Advisors's Vertex Pharmaceuticals position peaked at $4.24M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Richard Bernstein Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.